Shopping Cart 0
Cart Subtotal
AED 0

Rna Diagnostics Inc - Product Pipeline Analysis, 2018 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 2753

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 5505

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 8258
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Rna Diagnostics Inc (Rna Diagnostics) is a medical device company that discovers and develops medical diagnostics molecular diagnostic technologies. The company offers diagnostic tools used in treatment of women undergoing chemotherapy for breast cancer. It also provides solutions to manage cancer and other disease states. Rna Diagnostics' RNA disruption assay allows oncologists to examine the biological structure of a patient's tumor during treatment to determine its response to chemotherapy. The company collaborates with research clinicians, university researchers, and hospitals located in Canada, the US and other countries. It operates through its laboratories located across Ontario, Canada. Rna Diagnostics is headquartered in Toronto, Ontario, Canada.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Rna Diagnostics Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Rna Diagnostics Inc Company Overview 4

Rna Diagnostics Inc Company Snapshot 4

Rna Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Rna Diagnostics Inc-Pipeline Analysis Overview 6

Rna Diagnostics Inc-Key Facts 6

Rna Diagnostics Inc-Major Products and Services 7

Rna Diagnostics Inc Pipeline Products by Development Stage 8

Rna Diagnostics Inc Ongoing Clinical Trials by Trial Status 10

Rna Diagnostics Inc Pipeline Products Overview 11

RNA Disruption Assay-Breast Cancer 11

RNA Disruption Assay-Breast Cancer Product Overview 11

RNA Disruption Assay-Breast Cancer Clinical Trial 12

RNA Disruption Assay-Head & Neck Cancer 13

RNA Disruption Assay-Head & Neck Cancer Product Overview 13

RNA Disruption Assay-Ovarian Cancer 14

RNA Disruption Assay-Ovarian Cancer Product Overview 14

RNA Disruption Assay-Rectal Cancer 15

RNA Disruption Assay-Rectal Cancer Product Overview 15

RNA Disruption Assay-Sarcoma 16

RNA Disruption Assay-Sarcoma Product Overview 16

Rna Diagnostics Inc-Key Competitors 17

Rna Diagnostics Inc-Key Employees 18

Rna Diagnostics Inc-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Rna Diagnostics Inc, Recent Developments 20

May 17, 2018: Rna Diagnostics Aims for 2020 Clinical Launch of Breast Cancer Treatment Guidance Test 20

Apr 27, 2018: First patient enrolled in BREVITY, Rna Diagnostics' International Validation Trial of RDA in Primary Breast Cancer 21

Jul 06, 2017: Rna Diagnostics Appoints Dr. Matthew P. Goetz to Clinical Advisory Board 22

Jun 14, 2017: Rna Diagnostics Launches BREVITY-International Validation Trial of RDA in Breast Cancer 22

Sep 15, 2016: Further Evidence RDA May Predict Clinical Outcome Of Chemotherapy In Journal Of The National Cancer Institute 23

Apr 01, 2016: Rna Diagnostics appoints Dr. Jeremy Bridge-Cook President and CEO 24

Feb 18, 2016: Paul Lucas joins the Board of Directors at Rna Diagnostics 24

May 30, 2013: Rna Diagnostics Selected To Participate In Excite Program To Evaluate RNA Disruption Assay 25

Feb 19, 2013: Rna Diagnostics Gets USD462,500 Grant From FedDev Ontario For RNA Disruption Assay 25

Nov 02, 2012: Denis Ho joins Rna Diagnostics' Board of Directors 25

Appendix 27

Methodology 27

About GlobalData 30

Contact Us 30

Disclaimer 30


List Of Figure

List of Figures

Rna Diagnostics Inc Pipeline Products by Equipment Type 5

Rna Diagnostics Inc Pipeline Products by Development Stage 8

Rna Diagnostics Inc Ongoing Clinical Trials by Trial Status 10


List Of Table

List of Tables

Rna Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Rna Diagnostics Inc Pipeline Products by Equipment Type 5

Rna Diagnostics Inc Pipeline Products by Indication 5

Rna Diagnostics Inc Ongoing Clinical Trials by Trial Status 5

Rna Diagnostics Inc, Key Facts 6

Rna Diagnostics Inc, Major Products and Services 7

Rna Diagnostics Inc Number of Pipeline Products by Development Stage 8

Rna Diagnostics Inc Pipeline Products Summary by Development Stage 9

Rna Diagnostics Inc Ongoing Clinical Trials by Trial Status 10

Rna Diagnostics Inc Ongoing Clinical Trials Summary 10

RNA Disruption Assay-Breast Cancer-Product Status 11

RNA Disruption Assay-Breast Cancer-Product Description 11

RNA Disruption Assay-Breast Cancer-Breast Cancer Response Evaluation for Individualized Therapy: BREVITY 12

RNA Disruption Assay-Head & Neck Cancer-Product Status 13

RNA Disruption Assay-Head & Neck Cancer-Product Description 13

RNA Disruption Assay-Ovarian Cancer-Product Status 14

RNA Disruption Assay-Ovarian Cancer-Product Description 14

RNA Disruption Assay-Rectal Cancer-Product Status 15

RNA Disruption Assay-Rectal Cancer-Product Description 15

RNA Disruption Assay-Sarcoma-Product Status 16

RNA Disruption Assay-Sarcoma-Product Description 16

Rna Diagnostics Inc, Key Employees 18

Rna Diagnostics Inc, Other Locations 19

Glossary 29

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Rna Diagnostics Inc,Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Amico Corp

Diagnostics Biochem Canada Inc

GenePOC Inc

Biomedica Diagnostics Inc

Summary

Rna Diagnostics Inc (Rna Diagnostics) is a medical device company that discovers and develops medical diagnostics molecular diagnostic technologies. The company offers diagnostic tools used in treatment of women undergoing chemotherapy for breast cancer. It also provides solutions to manage cancer and other disease states. Rna Diagnostics' RNA disruption assay allows oncologists to examine the biological structure of a patient's tumor during treatment to determine its response to chemotherapy. The company collaborates with research clinicians, university researchers, and hospitals located in Canada, the US and other countries. It operates through its laboratories located across Ontario, Canada. Rna Diagnostics is headquartered in Toronto, Ontario, Canada.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Rna Diagnostics Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Rna Diagnostics Inc Company Overview 4

Rna Diagnostics Inc Company Snapshot 4

Rna Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Rna Diagnostics Inc-Pipeline Analysis Overview 6

Rna Diagnostics Inc-Key Facts 6

Rna Diagnostics Inc-Major Products and Services 7

Rna Diagnostics Inc Pipeline Products by Development Stage 8

Rna Diagnostics Inc Ongoing Clinical Trials by Trial Status 10

Rna Diagnostics Inc Pipeline Products Overview 11

RNA Disruption Assay-Breast Cancer 11

RNA Disruption Assay-Breast Cancer Product Overview 11

RNA Disruption Assay-Breast Cancer Clinical Trial 12

RNA Disruption Assay-Head & Neck Cancer 13

RNA Disruption Assay-Head & Neck Cancer Product Overview 13

RNA Disruption Assay-Ovarian Cancer 14

RNA Disruption Assay-Ovarian Cancer Product Overview 14

RNA Disruption Assay-Rectal Cancer 15

RNA Disruption Assay-Rectal Cancer Product Overview 15

RNA Disruption Assay-Sarcoma 16

RNA Disruption Assay-Sarcoma Product Overview 16

Rna Diagnostics Inc-Key Competitors 17

Rna Diagnostics Inc-Key Employees 18

Rna Diagnostics Inc-Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Rna Diagnostics Inc, Recent Developments 20

May 17, 2018: Rna Diagnostics Aims for 2020 Clinical Launch of Breast Cancer Treatment Guidance Test 20

Apr 27, 2018: First patient enrolled in BREVITY, Rna Diagnostics' International Validation Trial of RDA in Primary Breast Cancer 21

Jul 06, 2017: Rna Diagnostics Appoints Dr. Matthew P. Goetz to Clinical Advisory Board 22

Jun 14, 2017: Rna Diagnostics Launches BREVITY-International Validation Trial of RDA in Breast Cancer 22

Sep 15, 2016: Further Evidence RDA May Predict Clinical Outcome Of Chemotherapy In Journal Of The National Cancer Institute 23

Apr 01, 2016: Rna Diagnostics appoints Dr. Jeremy Bridge-Cook President and CEO 24

Feb 18, 2016: Paul Lucas joins the Board of Directors at Rna Diagnostics 24

May 30, 2013: Rna Diagnostics Selected To Participate In Excite Program To Evaluate RNA Disruption Assay 25

Feb 19, 2013: Rna Diagnostics Gets USD462,500 Grant From FedDev Ontario For RNA Disruption Assay 25

Nov 02, 2012: Denis Ho joins Rna Diagnostics' Board of Directors 25

Appendix 27

Methodology 27

About GlobalData 30

Contact Us 30

Disclaimer 30


List Of Figure

List of Figures

Rna Diagnostics Inc Pipeline Products by Equipment Type 5

Rna Diagnostics Inc Pipeline Products by Development Stage 8

Rna Diagnostics Inc Ongoing Clinical Trials by Trial Status 10


List Of Table

List of Tables

Rna Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Rna Diagnostics Inc Pipeline Products by Equipment Type 5

Rna Diagnostics Inc Pipeline Products by Indication 5

Rna Diagnostics Inc Ongoing Clinical Trials by Trial Status 5

Rna Diagnostics Inc, Key Facts 6

Rna Diagnostics Inc, Major Products and Services 7

Rna Diagnostics Inc Number of Pipeline Products by Development Stage 8

Rna Diagnostics Inc Pipeline Products Summary by Development Stage 9

Rna Diagnostics Inc Ongoing Clinical Trials by Trial Status 10

Rna Diagnostics Inc Ongoing Clinical Trials Summary 10

RNA Disruption Assay-Breast Cancer-Product Status 11

RNA Disruption Assay-Breast Cancer-Product Description 11

RNA Disruption Assay-Breast Cancer-Breast Cancer Response Evaluation for Individualized Therapy: BREVITY 12

RNA Disruption Assay-Head & Neck Cancer-Product Status 13

RNA Disruption Assay-Head & Neck Cancer-Product Description 13

RNA Disruption Assay-Ovarian Cancer-Product Status 14

RNA Disruption Assay-Ovarian Cancer-Product Description 14

RNA Disruption Assay-Rectal Cancer-Product Status 15

RNA Disruption Assay-Rectal Cancer-Product Description 15

RNA Disruption Assay-Sarcoma-Product Status 16

RNA Disruption Assay-Sarcoma-Product Description 16

Rna Diagnostics Inc, Key Employees 18

Rna Diagnostics Inc, Other Locations 19

Glossary 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Rna Diagnostics Inc,Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Amico Corp

Diagnostics Biochem Canada Inc

GenePOC Inc

Biomedica Diagnostics Inc